Genome research centre established in Shanghai:
This article was originally published in Clinica
Executive Summary
A human genome research centre has been set up in Shanghai to identify the genetic causes of disease and examine genomic structure and function. The centre is part of the China National Centre for Bioengineering Development and the Shanghai Science and Technology Commission. Universities, medical facilities and other Shanghai-based research institutes will be involved in the centre, which will initially focus on diseases of particular relevance to China, such as liver disorders, leukaemia, diabetes and cardiovascular disease, reports the Xinhua news agency.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.